Medicines discovery is changing. It is becoming more precise in its targeting and accompanied by more complex data, and advanced biomarkers and diagnostics. MDC is committed to working with innovative companies across the UK to accelerate this change; helping reshape drug discovery so that patients get the medicines they need faster.
We do this by championing innovative technology and new approaches. We thrive on innovation.
We provide extensive experience in industrial medicines discovery and informatics combined with access to innovative technologies, platforms, and outsourced, multiparty R&D. We can also help you access patient samples and valuable patient insights.
And we can get under the skin of your medicine discovery project, helping uncover the path to your success. Every new challenge brought to us is a chance to leverage our skills and capabilities, helping us to enhance the capabilities of our collaborators.
We offer solutions rather than services; projects rather than products. And if we’re not the best partner for you, we’ll find them. Our impact is measured by your success.
MDC’s collaborative culture is what makes us different. Every discussion with a member of the community is important, every problem is different, every solution and experimental plan is bespoke. We are as committed to the success of your project as you are, beside you for every step of your journey and we’ll share in your excitement whenever progress is made.
We work with you to understand your project’s needs and challenges, then we develop and implement an experimental plan that will deliver the data you need to accelerate your progress.
Our approach is open and impartial; our team should feel like an extension of your own. Based on your plan, you will access our expert teams across the MDC, and if we’re not the best partner, we’ll find them for you.
Some collaborators only need our help with one aspect of their project. Many find that we can help in many ways – from sample-sourcing to data extraction from hard to reach data sets; target engagement to AI curated insights; preclinical imaging to patient insights.
Our unrivalled network of R&D partners spans private and public sectors, taking in the NHS, universities, research institutes and CROs. It’s a network comprised of some of the sharpest minds that UK science and industry has to offer – skilled and dependable.